The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback